All Stories

  1. Exosome-mimetic nanocarriers in cancer diagnosis and drug delivery: engineering strategies, functional biomimicry, safety considerations, and clinical translation
  2. Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine
  3. Natural Products Targeting Notch Signaling in Cancer
  4. Antimicrobial self-healing injectable hydrogels based on chitosan, collagen, and polyvinyl alcohol for chronic wound treatment
  5. Targeting the Hippo/YAP Pathway: A Promising Approach for Cancer Therapy and Beyond
  6. Repurposing Poloxamers as Antimicrobial Agents: A Comprehensive Review of Mechanisms and Applications
  7. Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies
  8. Influencia del grado de desacetilación del quitosano en la síntesis de nanopartículas para aplicaciones farmacéuticas
  9. Magnolol and its semi-synthetic derivatives: a comprehensive review of anti-cancer mechanisms, pharmacokinetics, and future therapeutic potential
  10. Maytansinoids in cancer therapy: advancements in antibody–drug conjugates and nanotechnology-enhanced drug delivery systems
  11. Skin Disorders and Quality of Life: An Overview
  12. D1 Receptor Functional Asymmetry at Striatonigral Neurons: A Neurochemical and Behavioral Study in Male Wistar Rats
  13. Nanoparticle and microparticle-based systems for enhanced oral insulin delivery: A systematic review and meta-analysis
  14. Unlocking the biological potential of methyl antcinate A: a new frontier in cancer and inflammation application
  15. Current Overview of Spinocerebellar Ataxia Type 7 in Mexican Population: Challenges in Specialized Care for a Rare Disease
  16. Unrevealing Lithium Repositioning in the Hallmarks of Cancer: Effects of Lithium Salts (LiCl and Li2CO3) in an In Vitro Cervical Cancer Model
  17. Natural products‐based antiangiogenic agents: New frontiers in cancer therapy
  18. Cacalol Acetate as Anticancer Agent: Antiproliferative, Pro-Apoptotic, Cytostatic, and Anti-Migratory Effects
  19. Cacalol Acetate as Anticancer Agent: Anti-proliferative, Pro-apoptotic, Cytostatic and Anti-migratory Effects
  20. Biopolymeric Insulin Membranes for Antimicrobial, Antioxidant, and Wound Healing Applications
  21. Polymeric nanoparticles decorated with fragmented chitosan as modulation systems for neuronal drug uptake
  22. Genipin’s potential as an anti-cancer agent: from phytochemical origins to clinical prospects
  23. New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives
  24. Nutritional Sources and Anticancer Potential of Phenethyl Isothiocyanate: Molecular Mechanisms and Therapeutic Insights
  25. Review of the anticancer properties of 6‐shogaol: Mechanisms of action in cancer cells and future research opportunities
  26. Optimize the parameters for the synthesis by the ionic gelation technique, purification, and freeze-drying of chitosan-sodium tripolyphosphate nanoparticles for biomedical purposes
  27. Modulation of D3R Splicing, Signaling, and Expression by D1R through PKA→PTB Phosphorylation
  28. Skin Disorders and Quality of Life: An Overview
  29. Dopamine D3 receptor modulates D2 receptor effects on cAMP and GABA release at striatopallidal terminals—Modulation by the Ca2+–Calmodulin–CaMKII system
  30. Essential-Oils-Loaded Biopolymeric Nanoparticles as Strategies for Microbial and Biofilm Control: A Current Status
  31. Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
  32. Novel ultra-stretchable and self-healing crosslinked poly (ethylene oxide)-cationic guar gum hydrogel
  33. 3,3′-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways
  34. Recombinant Antibodies to Face SARS-CoV-2 Syndemic
  35. High Levels of Anxiety, Depression, Risk of Suicide, and Implications for Treatment in Patients with Lamellar Ichthyosis
  36. Neopeltolide and its synthetic derivatives: a promising new class of anticancer agents
  37. PEG 400:Trehalose Coating Enhances Curcumin-Loaded PLGA Nanoparticle Internalization in Neuronal Cells
  38. Enhancing chemical and physical stability of pharmaceuticals using freeze-thaw method: challenges and opportunities for process optimization through quality by design approach
  39. Current Status of the Therapeutic Approach for Dysmenorrhea
  40. Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain
  41. Lithium: A Promising Anticancer Agent
  42. Discovering the effect of solvents on poly(2-aminoethyl methacrylate) grafting onto chitosan for an in vitro skin model
  43. Study of Traditional Uses, Extraction Procedures, Phytochemical Constituents, and Pharmacological Properties of Tiliacora triandra
  44. Preparation of chitosan-graft N-hydroxyethyl acrylamide copolymers as an in vitro-engineered skin
  45. Repositioning of drugs for Parkinson’s disease and pharmaceutical nanotechnology tools for their optimization
  46. Presynaptic nigral GPR55 receptors stimulate [ 3 H]‐GABA release through [ 3 H]‐cAMP production and PKA activation and promote motor behavior
  47. Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest
  48. The high methylation level of a novel 151-bp CpG island in the ESR1 gene promoter is associated with a poor breast cancer prognosis
  49. A poly (saccharide-ester-urethane) scaffold for mammalian cell growth
  50. Gamma radiation-induced grafting of poly(2-aminoethyl methacrylate) onto chitosan: A comprehensive study of a polyurethane scaffold intended for skin tissue engineering
  51. Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer
  52. Alterations in mental health and quality of life in patients with skin disorders: a narrative review
  53. Therapeutic Applications of Terpenes on Inflammatory Diseases
  54. A NEW FORMULATION OF CINNAMON OIL AND CHITOSAN DEPOLYMERIZED AGAINST OPPORTUNISTIC MICROORGANISMS DURING WOUND HEALING
  55. Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses
  56. Current progress of self-healing polymers for medical applications in tissue engineering
  57. Insights into Terminal Sterilization Processes of Nanoparticles for Biomedical Applications
  58. Antioxidant potential of family Cucurbitaceae with special emphasis on Cucurbita genus: A key to alleviate oxidative stress‐mediated disorders
  59. Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials
  60. Association of TLR4 gene polymorphisms with sepsis after a burn injury: findings of the functional role of rs2737190 SNP
  61. Curcumin for parkinson´s disease: potential therapeutic effects, molecular mechanisms, and nanoformulations to enhance its efficacy
  62. Development of a guar gum film with lysine clonixinate for periodontal treatments
  63. Development of a xanthan gum film for the possible treatment of vaginal infections
  64. Development of films from natural sources for infections during wound healing
  65. Physicochemical and biological characterization of a xanthan gum-polyvinylpyrrolidone hydrogel obtained by gamma irradiation
  66. Radiation-induced graft polymerization of elastin onto polyvinylpyrrolidone as a possible wound dressing
  67. Synthesis by gamma irradiation of hyaluronic acid-polyvinyl alcohol hydrogel for biomedical applications
  68. Repurposing of Drug Candidates for Treatment of Skin Cancer
  69. Increased risk of depression and impairment in quality of life in patients with lamellar ichthyosis
  70. Dopamine D4 receptor modulates inhibitory transmission in pallido‐pallidal terminals and regulates motor behavior
  71. Gamma radiation-induced grafting of n-hydroxyethyl acrylamide onto poly(3-hydroxybutyrate): A companion study on its polyurethane scaffolds meant for potential skin tissue engineering applications
  72. Chitosan-decorated nanoparticles for drug delivery
  73. A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier
  74. Radiation-induced PEGylated Ethambutol Has Low Antimycobacterial Activity in Vitro
  75. RECENT ADVANCES IN ELASTIN-BASED BIOMATERIALS
  76. Coexistence of Fragile-X Syndrome, 8p23.1 Deletion, and Balanced Translocation t(7;10)(p10;q24) in a Single Family
  77. Xanthan gum in drug release
  78. Hyaluronic acid in wound dressings
  79. High prevalence of autosomal recessive congenital ichthyosis in a Mexican population caused by a new mutation in the TGM1 gene: epidemiological evidence of a founder effect
  80. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases
  81. Altered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7
  82. Coexistence of D 3 R typical and atypical signaling in striatonigral neurons during dopaminergic denervation. Correlation with D 3 nf expression changes
  83. Breast cancer-related single-nucleotide polymorphism and their risk contribution in Mexican women
  84. D 2 autoreceptor switches CB 2 receptor effects on [ 3 H]‐dopamine release in the striatum
  85. Non-invasive methods for evaluation of skin manifestations in patients with ichthyosis
  86. Pharmacological treatments for cutaneous manifestations of inherited ichthyoses
  87. Blockade of Intranigral and Systemic D3 Receptors Stimulates Motor Activity in the Rat Promoting a Reciprocal Interaction Among Glutamate, Dopamine, and GABA
  88. Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
  89. Development and Evaluation of Alginate Membranes with Curcumin-Loaded Nanoparticles for Potential Wound-Healing Applications
  90. Modifications in Vaginal Microbiota and Their Influence on Drug Release: Challenges and Opportunities
  91. Oropharyngeal dysphagia in early stages of myotonic dystrophy type 1
  92. Presynaptic Control of [3H]-Glutamate Release by Dopamine Receptor Subtypes in the Rat Substantia Nigra. Central Role of D1 and D3 Receptors
  93. Formulations of Curcumin Nanoparticles for Brain Diseases
  94. Effects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7
  95. Non-invasive analysis of skin mechanical properties in patients with lamellar ichthyosis
  96. Comprehensive mapping of human body skin hydration: A pilot study
  97. Presynaptic cannabinoid CB2 receptors modulate [3 H]-Glutamate release at subthalamo-nigral terminals of the rat
  98. From traditional biochemical signals to molecular markers for detection of sepsis after burn injuries
  99. Origin of the myotonic dystrophy type 1 mutation in Mexican population and influence of Amerindian ancestry on CTG repeat allelic distribution
  100. Presynaptic Dopamine D2 Receptors Modulate [ 3 H]GABA Release at StriatoPallidal Terminals via Activation of PLC → IP3 → Calcineurin and Inhibition of AC → cAMP → PKA Signaling Cascades
  101. Nanotechnology As Potential Tool for siRNA Delivery in Parkinson's Disease
  102. Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent
  103. Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain
  104. Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca2+ dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat
  105. Detección de la duplicación del gen PMP22 en pacientes con neuropatía periférica: estudio en la población mexicana
  106. Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca2+ dependent manner
  107. Origin of the Spinocerebellar Ataxia Type 7 Gene Mutation in Mexican Population
  108. GABAB receptors modulate depolarization-stimulated [3H]glutamate release in slices of the pars reticulata of the rat substantia nigra
  109. L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors